Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with non-small cell lung cancer (a specific type of lung cancer) at an advanced stage (stage 3B or stage 4), and who are receiving one of the immunotherapy drugs pembrolizumab, atezolizumab, or nivolumab (with or without chemotherapy) as part of their treatment — whether before surgery, after surgery, or to manage the disease long-term — at Ysbyty Gwynedd hospital.
- People whose general health and ability to carry out daily activities meets a certain minimum level, as measured by a standard medical scale (a score of less than 2 on the WHO performance status scale) (confirm with trial site).
- People who are able to make their own informed decisions about participating.
- People who do not have other health conditions that are currently uncontrolled or poorly managed.
- People who are able to wear a biosensor bracelet (a wearable health-monitoring device).
- People who are able to understand English.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose general health and ability to carry out daily activities falls below a certain level on a standard medical scale (a score of more than 2 on the WHO performance status scale) (confirm with trial site).
- People who have other health conditions that are currently uncontrolled or poorly managed.
- People who are not able to make their own informed decisions about participating.
- People who are unable to wear the biosensor bracelet.
- People who have complete hair loss (no hair remaining on the head).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Is TimeTeller able to identify the molecular clock phase in patients with advanced NSCLC from analysis of hair samples/buccal mucosa in at least 75% of the participants?
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.